Biomaterials Market Size, Share & Trends Analysis Report By Product (Natural, Metallic, Ceramics, Polymers), By Application (Cardiovascular, Orthopedics, Plastic Surgery), And Segment Forecasts, 2018 - 2025

Industry Insights

The global biomaterials market size was valued at USD 83.9 billion in 2017 and is likely to register a CAGR of 14.7% over the forecast period. Rising occurrence of cardiovascular diseases and orthopedic disorders worldwide, development of implantable instruments and materials, growing number of hip and knee replacement surgeries, advancements in tissue designing, and expanding geriatric population are factors likely to drive the market over the forecast period.

Growing number of clinical diagnostic research studies, increasing R&D investments in molecular biology and precision medicine, and rising private and public partnerships in life science and biotechnology are some of the factors indirectly driving the market.

New entrants in the market are expected to offer stiff competition to established players owing to constant innovation taking place in this field. Nevertheless, leading players will continue to contribute significantly to market growth by focusing on development of new technologies and biomaterial products.

Factors such as stringent regulatory approvals related to commercialization of these materials, inadequate supply of natural tissues, lack of reimbursement policies, and problems pertaining to biocompatibility of biomaterials with living tissues are restraining the market.

Products Insights

Based on the kind of material used, the biomaterials market can be classified into metallic, natural, ceramics, and polymers. Metallic biomaterials include steel, titanium and titanium amalgams, cobalt-chrome combinations, silver, gold, and magnesium, among others.

The polymers segment includes materials made up of silicone elastic, polyethylene, nylon, PLGA, polyester, polyvinyl chloride, and other polymers. This segment emerged dominant in 2017 and is expected to retain its lead throughout the forecast period. Natural biomaterials comprise plant- and animal-based materials such as sodium alginate, cellulose, and natural rubber, tissue-based heart valves, collagen, sutures, hyaluronic acid glycosaminoglycans, and heparin. This segment is expected to register the fastest growth by 2025.

Ceramic biomaterials are made up of alumina, calcium phosphates, bio-glass ceramics and pyrolytic carbon, among others. Ceramics have been successfully used in the repair of hard tissues in orthopedics and dental applications. Most categories of biomaterials are used for restoration of damaged tissues and tissue fixation in surgeries and tissue replacements.

Application Insights

Based on the application of biomaterials in a number of healthcare domains, the market can be segmented into cardiovascular, ophthalmology, dental, orthopedic, wound healing, tissue engineering, and plastic surgery. The cardiovascular segment includes materials such as sensors, stents, guidewires, implantable cardiac defibrillators, pacemakers, and vascular grafts.

The cardiovascular segment is highly lucrative and is estimated to register a CAGR of 15.4% during the forecast period. Segment growth can be attributed to due to increasing cases of heart ailments and complications. The plastic surgery segment is likely to expand at the fastest CAGR of 16.2% during the forecast period, followed by ophthalmology.

Within plastic surgery, biomaterials are used in facial wrinkle treatment, soft tissue fillers, craniofacial surgery, bioengineered skins, peripheral nerve repair, and acellular dermal matrices. This segment is driven by growing trend of cosmetic procedures, increased demand for fat transfer and fat freezing, and increase in demand from the male consumer segment. Obtrusive corrective medical procedures and positive recognition for the same is also driving this segment.

Regional Insights

Currently, North America holds the largest revenue share in the market and Asia Pacific is poised to emerge as the fastest growing region by 2025. Factors such as growing industrialization in both developed and developing nations, strong government support, suitable strategic framework, and continuous R&D are expected to drive the market in future.

Asia Pacific, especially economies such as China, India, Japan, and Korea, is a highly lucrative market driven by changing trends. The market is slated to register a CAGR of 15.6% during the forecast period and emerge as an income stash for organizations offering biomaterials.

Biomaterials Market Share Insights

These materials can be used in place of living tissues wherever compatible and find wide application scope in surgeries, cartilage regeneration, and as a substitute for bones. Thus, leaders in this market are now inclined toward development of more innovative products. In addition, local companies and new entrants are significantly investing in strategic agreements with global firms for business expansions related to research and development in the field.

Some of the major companies operating in this market are DSM; BASF SE; Evonik Industries AG; Berkeley Advanced Biomaterials, Inc.; CAM Bioceramics BV; Carpenter Technology Corporation; Invibio Ltd.; Zimmer Biomet Holdings, Inc.; Covalon Technologies Ltd.; Collagen Matrix, Inc.; Medtronic, Inc.; Purac Biomaterials; Ticona GmbH; Osteotech, Inc.; and Bayer AG.

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on latest industry trends in each of the sub-segments from 2014 to 2025. For this study, Grand View Research has segmented the global biomaterials market report based on product, application, and region:

• Product Outlook (Revenue, USD Million, 2014 - 2025)

  • Metallic

  • Natural

  • Ceramics

  • Polymers

• Application Outlook (Revenue, USD Million, 2014 - 2025)

  • Cardiovascular

    • Sensors

    • Stents

    • Guidewires

    • Implantable Cardiac Defibrillators

    • Pacemakers

    • Vascular Grafts

    • Others

  • Ophthalmology

    • Synthetic Corneas

    • Intraocular Lens

    • Contact Lens

    • Ocular Tissue Replacement

    • Others

  • Dental

    • Tissue Regeneration Materials

    • Dental Implants

    • Bone Grafts & Substitutes

    • Dental Membranes

    • Others

  • Orthopedic

    • Joint Replacement biomaterials

    • Orthobiologics

    • Bioresorbable Tissue Fixation Products

    • Viscosupplementation

    • Spine Biomaterial

    • Others

  • Wound Healing

    • Fracture Healing Device

    • Adhesion Barrier

    • Skin Substitutes

    • Internal Tissue Sealant

    • Surgical Hemostats

    • Others

  • Tissue Engineering

  • Plastic Surgery

    • Facial Wrinkle Treatment

    • Soft Tissue Fillers

    • Craniofacial Surgery

    • Bioengineered Skins

    • Peripheral Nerve Repair

    • Acellular Dermal Matrices

    • Others

  • Neurology

    • Neural Stem Cell Encapsulation

    • Shunting Systems

    • Hydrogel Scaffold For CNS Repair

    • Cortical Neural Prosthetics

    • Others

  • Others

• Regional Outlook (Revenue, USD Million, 2014 - 2025)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

  • Asia Pacific

    • Japan

    • China

  • Latin America

    • Brazil

    • Mexico

  • Middle East Africa

    • South Africa